Nanoemulsion - Based Cosmeceuticals: Formulation Strategies and Quality by Design Approach- A Comprehensive Review

The cosmetic industry has swiftly progressed from traditional beauty products to advanced cosmeceuticals with both aesthetic and medicinal properties. Modern cosmetic formulations increasingly formulated not just to improve appearance but also to deliver biologically active chemicals that promote skin health, hydration, anti-aging properties, and photo protection. However, many conventional cosmetic formulations have disadvantages such as low solubility of active ingredients, insufficient stability, and restricted penetration across the skin barriers.

Nanotechnology has emerged as a useful technique for addressing these difficulties. Nanoemulsions have gained popularity in cosmetic and pharmaceutical formulations because to their small droplet size, huge surface area, and improved physicochemical stability. These systems typically comprise oil, water, surfactants, and co-surfactants that create nanosized droplets capable of enhancing active chemical solubilization and cutaneous administration. Because of these benefits, nanoemulsions are commonly used in products such as moisturizers, sunscreens, anti-aging creams, and therapeutic skincare formulas.(15,17) Despite their benefits, developing stable nanoemulsion systems is challenging since formulation composition and processing factors have a significant impact on droplet size, stability, and performance. In recent years, the Quality by Design (QbD) method has gained prominence as a systematic framework for formulation development. QbD focuses on a detailed understanding of formulation variables and process parameters to assure consistent product quality, safety, and efficacy. The QbD technique involves determining critical quality attributes (CQAs), critical material attributes (CMAs), and critical process parameters (CPPs). The QbD technique allows for optimal and reproducible nanoemulsion formulations. (10,11)

These review paper also discusses nanoemulsion preparation methods, uses in cosmetic items and the significance of statistical tools such as Design of Experiments (DoE) in attaining robust formulation development.

NANOEMULSIONS:

Nanoemulsions are nano scale dispersions composed of two immiscible liquids stabilized by surfactants. Although they are thermodynamically unstable systems, they exhibit significant kinetic stability due to their extremely small droplet size. , Flow chart of Mechanism of nanoemulsion based cosmeceuticals with QbD approach followed in Fig.1

Fig .1 Mechanism of nanoemulsion of cosmeceuticals by QbD Approach

Fig.2. Mechanism of Skin Cosmotherapeutics by Nano emulsion

 

 

Fig.3. Basic Structure of Water-in-Oil and Oil-in-Water Emulsions

 

Fig.4. Selection of nano emulsion components

Fig. 5 Methods of preparation of nanoemulsion formulation

5. DESIGN OF EXPERIMENTS (DOE)

Design of Experiments (DoE) is a systematic statistical approach used in the Quality by Design (QbD) framework better understand the link between formulation variables and product quality. In nanoemulsion-based nanocosmetics, DoE aids in determining the best mix of ingredients and processing conditions required to achieve desired quality features such as small droplet size, high stability, and uniform dispersion.

Factorial designs and response surface methodology used to optimize formulation variables and establish design space. (8, 9, 12) Key QbD elements and Statistical tools used in Design of Experiments for optimization of Nanoemulsion formulations is followed in Table.9

6. Procedure for QbD Application in Nanoemulsion Development (9, 10, 11, 14)

The implementation of QbD in nanoemulsion formulation involves the following steps:

Step 1: Define QTPP (Quality Target Product Profile)

• Desired properties: droplet size, stability, skin compatibility, release profile.

Step 2: Identify CQAs

• Droplet size, PDI, zeta potential, viscosity, drug release.

Step 3: Identify CMAs and CPPs

• CMAs: oil type, surfactant concentration, Smix ratio.
• CPPs: homogenization speed, sonication time, temperature.

Step 4: Risk Assessment

• Use Ishikawa diagram and FMEA to identify high-risk variables.

Step 5: Experimental Design (DoE)

• Select design (Box–Behnken, Central Composite Design).
• Define independent variables (e.g., oil percentage, surfactant %, speed).
• Define responses (e.g., droplet size, PDI, zeta potential).

Step 6: Data Analysis & Optimization

• Use software (Design-Expert, Minitab).
• Generate response surface plots.
• Identify optimal formulation.

Step 7: Design Space Establishment

• Define range where CQAs remain acceptable.

Step 8: Validation

• Prepare optimized batch.
• Compare predicted vs experimental results.

Step 9: Control Strategy

• Maintain consistency during scale-up and production.

5. CHALLENGES AND LIMITATIONS

• Sensitivity to formulation and processing conditions:

Nanoemulsions are highly dependent on formulation composition (oil, surfactant ratio) and processing parameters (temperature, homogenization). Small variations can lead to significant changes in droplet size, polydispersity, and stability, affecting product performance and reproducibility.(16,17,19)

• High surfactant concentration:

To achieve stability, nanoemulsions often require higher amounts of surfactants, which may cause skin irritation, toxicity, or allergic reactions upon prolonged use, especially in sensitive skin formulations.(22,24,25)

6. SUMMARY

The adoption of the Quality by Design (QbD) approach in nanoemulsion-based cosmeceutical development marks a shift away from traditional formulation approaches and toward a more structured and science-driven process. Unlike traditional trial-and-error procedures, which frequently lack consistency and process awareness, QbD emphasizes the proactive integration of quality into both formulation and manufacturing processes from the start.

Nanoemulsions have significant interfacial surface area and nanoscale droplet size, making them complex and sensitive systems (17). These properties render them susceptible to physical instability mechanisms such as creaming, flocculation, and coalescence. The QbD framework allows for a comprehensive understanding of the factors that influence formulation performance and stability by linking the Quality Target Product Profile (QTPP) with Critical Quality Attributes (CQAs), Critical Material Attributes (CMAs), and Critical Process Parameters (CPPs). This integrated method assures that the final product constantly fulfills predetermined quality, safety, and efficacy standards.

Among the identified CQAs, droplet size and polydispersity index (PDI) are critical in determining nanoemulsion behavior. These factors have a direct impact on not just physical stability, but also skin penetration, visual appearance, and sensory properties, all of which are crucial for consumer approval of cosmetic products. The use of systematic risk assessment methods like Ishikawa diagrams and Failure Mode and Effects Analysis (FMEA) enables the identification of high-impact variables in CMAs and CPPs. As a result, formulation efforts can be strategically oriented toward regulating these essential parameters, increasing efficiency and minimizing development time.

The increased demand for herbal and organically derived cosmetic actives continues emphasizes the importance of QbD in nanoemulsion systems. Such bioactives frequently present problems like poor water solubility, sensitivity to degradation, and unpredictability in function. QbD facilitates the stabilization and effective delivery of these sensitive compounds by selecting and optimizing formulation components such as oil phase, surfactant systems, and stabilizers, as well as precisely controlling processing conditions. This improves both product performance and shelf life.

Furthermore, including Design of Experiments (DoE) into the QbD framework provides a useful tool for assessing the combined impacts of various factors. Unlike traditional one-factor-at-a-time approaches, DoE allows for the detection of interaction effects and aids in the construction of prediction models. The creation of a well-defined design space guarantees that acceptable product quality is maintained even with modest alterations in formulation or processing conditions, increasing robustness and allowing scale-up for industrial production. Although originally created for pharmaceutical development, the use of QbD concepts in cosmetics is becoming increasingly significant as regulatory standards rise and consumers seek safe, effective, and scientifically validated goods. Overall, applying QbD to nanoemulsion-based cosmeceuticals provides a dependable and forward-thinking technique for achieving consistent product quality, increased performance and successful commercialization.

CONCLUSION

The advancement of nanoemulsion-based nano cosmetics highlights the need for a more rational and controlled formulation strategy, which is effectively addressed by the Quality by Design (QbD) approach. By integrating scientific understanding with statistical optimization tools, QbD enables precise control over formulation variables and processing conditions, resulting in improved product reliability and reproducibility.

This approach is particularly valuable in managing the complexities associated with nanoscale systems, including stability challenges and variability in performance. It also supports the efficient incorporation of bioactive compounds by enhancing their protection and delivery within the formulation matrix.

In the context of evolving regulatory expectations and increasing demand for high-performance cosmetic products, QbD-driven nanoemulsion development offers a robust pathway for innovation, scalability, and commercialization.

Conflict of interest: No conflict of interest

REFERENCES

1. Shah, R., Gandhi, J., Shah, M., Tiwari, P., Chaudhary, B., & Shah, V. (2025). Nanoemulsions for topical delivery: Formulation, applications, and recent advances. Journal of Microencapsulation, 42(7), 660–681.
2. Chavan, S. V., Guha, S., Raza, K., Pandit, R. K., Pandit, K., & Chitkara, D. (2025). QbD-optimized nanoemulsion-based topical formulation of Jatyadi Taila. Pharmaceutical Research.
3. Mushtaq, A., Wani, S. M., Malik, A. R., et al. (2023). Recent insights into nanoemulsions: Preparation, properties, and applications. Food Chemistry X, 18, 100655.
4. Abu-Huwaij, R., Al-Assaf, S. F., & Hamed, R. (2022). Nanoemulsions in cosmeceutical delivery. Journal of Cosmetic Dermatology, 21(9), 3729–3740.
5. Acharya, S. D., Tamane, P. K., Khante, S. N., & Pokharkar, V. B. (2020). QbD-based optimization of curcumin nanoemulsion. Indian Journal of Pharmaceutical Education and Research, 54(2), 329–336.
6. Patel, A. R., & Velikov, K. P. (2011). Colloidal delivery systems in foods and cosmetics. LWT - Food Science and Technology, 44(9), 1958–1964.
7. Marzuki, H. C., Wahab, R. A., & Hamid, M. A. (2019). Overview of nanoemulsion development and cosmeceutical applications. Biotechnology & Biotechnological Equipment, 33(1), 779–797.
8. Namjoshi, S., Dabbaghi, M., Roberts, M. S., Grice, J. E., & Mohammed, Y. (2020). Quality by design for semisolid topical products. Pharmaceutics, 12(3), 287.
9. Beg, S., Rahman, M., Jain, A., et al. (2015). Application of quality by design approach for nanoemulsion formulations. International Journal of Pharmaceutics, 491(1–2), 1–12.
10. Yu, L. X. (2008). Pharmaceutical quality by design: Product and process development, understanding, and control. Pharmaceutical Research, 25(4), 781–791.
11. International Council for Harmonisation. (2009). ICH Q8 (R2): Pharmaceutical development.
12. Amasya, G., Ozturk, C., & Tarimci, N. (2021). Quality by design-based optimization of nano-cosmeceuticals. Journal of Drug Delivery Science and Technology, 66, 102737.
13. Implementation of QbD for nanoformulated cosmeceuticals. (2024). Nanocosmeceutical Review.
14. Sharma, G., & Dua, K. (2023). Application of quality by design in nanotechnology-based drug delivery systems. Drug Delivery Science and Technology, 81, 104201.
15. Solans, C., Izquierdo, P., Nolla, J., Azemar, N., & Garcia-Celma, M. J. (2005). Nano-emulsions. Current Opinion in Colloid & Interface Science, 10(3–4), 102–110.
16. Tadros, T., Izquierdo, P., Esquena, J., & Solans, C. (2004). Formation and stability of nanoemulsions. Advances in Colloid and Interface Science, 108–109, 303–318.
17. McClements, D. J. (2012). Nanoemulsions versus microemulsions: Terminology, differences, and similarities. Soft Matter, 8(6), 1719–1729.
18. Gupta, A., Eral, H. B., Hatton, T. A., & Doyle, P. S. (2016). Nanoemulsions: Formation, properties, and applications. Soft Matter, 12(11), 2826–2841.
19. Kotta, S., Khan, A. W., Ansari, S. H., & Sharma, R. K. (2015). Formulation of nanoemulsion systems. Drug Delivery, 22(4), 455–466.
20. Date, A. A., & Nagarsenker, M. S. (2008). Design and evaluation of microemulsions.AAPS PharmSciTech, 9(1), 138–145.
21. Lademann, J., Richter, H., Schanzer, S., et al. (2011). Penetration of nanoparticles into human skin. European Journal of Pharmaceutics and Biopharmaceutics, 77(3), 465–468.
22. Trommer, H., & Neubert, R. H. H. (2006). Overcoming the stratum corneum barrier: The modulation of skin penetration. Skin Pharmacology and Physiology, 19(2), 106–121.
23. Zsikó, S., Csányi, E., Kovács, A., et al. (2019). Methods to evaluate skin penetration in vitro. Scientia Pharmaceutica, 87(3), 19.
24. Khezri, K., Saeedi, M., & Maleki Dizaj, S. (2018). Nanoparticles in dermatology and cosmetics. Biomedicine & Pharmacotherapy, 110, 241–251.
25. Gupta, V., Mohapatra, S., Mishra, H., et al. (2022). Nanotechnology in cosmetics: Current trends and future perspectives. Gels, 8(3), 173.
26. Zoabi, A., Touitou, E., & Margulis, K. (2021). Nanomaterials for dermal and transdermal drug delivery. Colloids and Interfaces, 5(1), 18.
27. Shakeel, F., Ramadan, W., & Shafiq, S. (2009). Nanoemulsion as a drug delivery system. Journal of Bioequivalence & Bioavailability, 1(2), 39–43.
28. Khurana, S., Jain, N. K., & Bedi, P. M. S. (2013). Nanoemulsion-based gel for transdermal delivery. Life Sciences, 92(6–7), 383–392.
29. Algahtani, M. S., Ahmad, M. Z., & Ahmad, J. (2020). Nanoemulgel: A promising topical drug delivery system. Nanomaterials, 10(5), 848.
30. Luo, L., Patel, A., Sinko, P., et al. (2015). Topical delivery of active pharmaceutical ingredients. International Journal of Pharmaceutics, 481(1–2), 1–10.
31. Sadick, N. (2019). Advances in cosmetic dermatology. International Journal of Women’s Dermatology, 5(1), 1–3.
32. Iskandar, B., Liu, T., Mei, H., et al. (2024). Herbal nanoemulsions in cosmetics. Journal of Food and Drug Analysis, 32(1), 45–67.
33. Lintner, K., & Peschard, O. (2009). Biologically active ingredients in cosmetics. Clinics in Dermatology, 27(5), 461–465.
34. Venus, M., Waterman, J., & McNab, I. (2010). Basic skin physiology. Surgery, 28(10), 469–472.
35. Cholakova, D., Vinarov, Z., & Denkov, N. (2022). Self-emulsification techniques and applications.
36. Li, M., Cai, J., & Gao, Y. (2025). Advances in nanoparticle synthesis and applications.
37. Cholakova, D., & Tcholakova, S. (2025). Surfactants in nanoemulsion systems.
38. Bazazi, P., & Hejazi, S. H. (2020). Double emulsions: Formation and stability.
39. Cunha, S., Costa, C. P., Moreira, J. N., Lobo, J. M. S., & Silva, A. C. (2020a). Using the quality by design (QbD) approach to optimize formulations of lipid nanoparticles and nanoemulsions: A review. Nanomedicine Nanotechnology Biology and Medicine, 28, 102206.
40. Chuo, S. C., & Setapar, S. H. M. (2022). Application of nanoemulsion in cosmetics. In Elsevier eBooks (pp. 355–371).
41. De Souza, A. C., Sipoli, C. C., Aranha, A. C. R., Samulewski, R. B., Da Silva, G. N., Defendi, R. O., Gomes, M. C. S., & Suzuki, R. M. (2026a). Applicability of nanoemulsions for the incorporation of bioactive compounds in cosmetics: a review. ACS Omega, 11(4), 4818–4842. Deveci, E. (2025). Nanoemulsions in cosmetics: Enhancing efficacy and stability. Journal of Dermatologic Science and Cosmetic Technology, 100107.
42. G, R., A, S., Y, H. E. T., & D, P. (2025a). COMPREHENSIVE REGULATIONS FOR
43. DRUG AND COSMETICS IN EUROPEAN UNION. International Journal of Pharmacy and Pharmaceutical Sciences, 26–32.
44. Grangeia, H. B. (2026). “Quality by Design Approach in Nanotechnology Applied to Cosmetics: A Systematic Review From Conception to Production.” Journal of Dermatologic Science and Cosmetic Technology, 100145.
45. Gupta, V., Mohapatra, S., Mishra, H., Farooq, U., Kumar, K., Ansari, M., Aldawsari, M., Alalaiwe, A., Mirza, M., & Iqbal, Z. (2022). Nanotechnology in Cosmetics and Cosmeceuticals—A review of latest advancements. Gels, 8(3), 173.
46. Jaiswal, M., Dudhe, R., & Sharma, P. K. (2014). Nanoemulsion: an advanced mode of drug delivery system. 3 Biotech, 5(2), 123–127.
47. Yu, L. X., Amidon, G., Khan, M. A., Hoag, S. W., Polli, J., Raju, G. K., & Woodcock, J. (2014a). Understanding pharmaceutical quality by design. The AAPS Journal, 16(4), 771–783.
48. Yang, S., Hu, X., Zhu, J., Zheng, B., Bi, W., Wang, X., Wu, J., Mi, Z., & Wu, Y. (2025). Aspects and Implementation of Pharmaceutical Quality by Design from Conceptual Frameworks to Industrial Applications. Pharmaceutics, 17(5), 623.
49. Zagalo, D. M., Silva, B. M., Silva, C., Simões, S., & Sousa, J. J. (2022). A quality by design (QbD) approach in pharmaceutical development of lipid-based nanosystems: A systematic review. Journal of Drug Delivery Science and Technology, 70, 103207.
50. Mohd-Setapar, S., John, C., Mohd-Nasir, H., Azim, M., Ahmad, A., & Alshammari, M. (2022). Application of Nanotechnology Incorporated with Natural Ingredients in Natural Cosmetics. Cosmetics, 9(6), 110.